American Healthcare Capital is pleased to introduce a $26.5 Million Long Term Care and Retail Pharmacy with locations in the Washington DC, Metropolitan area. The company has a long-standing presence within the local community and is a provider of Long Term Care, Retail, Compounding and Transplant medication services.
The company has grown steadily each year. In 2016, they generated approximately $22.7 Million in revenue and grew to over $24 Million in 2017 ($6.4 Million from LTC Rx Services) with an adjusted EBITDA of nearly $1.4 Million (5.67%). In 2018, the company is expected to gross $26.5 Million in revenue with an adjusted EBITDA margin of $1.59 Million (6%). Approximately $8.4 Million of that revenue will come from LTC Rx services. Their Transplant and Compounding business comprise a small portion of total revenue.
The seller is contemplating retirement but would prefer to remain employed post-acquisition for the right opportunity. The seller would also consider selling each entity (LTC Rx or Retail locations) separately. The asking price for the opportunity is $15 Million, plus the cost of inventory.
If you would like to learn more, please contact us for a Confidentiality Agreement that will allow us to share more detailed information with you.